Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VALID 0 palatability testing of pediatric valacyclovir formulations
NL-OMON43617Recruiting
- Sponsor
- Nederlandse Federatie van Universitair Medische Centra
- Start
- Nov 2015
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of valaciclovir in Varicella zoster infection and herpes simplex (HSV) (2 arms), sponsored by Nederlandse Federatie van Universitair Medische Centra. Primary endpoint: Palatability of each formulation in children. Started Nov 2015; status: recruiting.
02
Drugs
valaciclovir
03
Conditions
Varicella zoster infectionherpes simplex (HSV)
Beyond the preview
Go deeper on NL-OMON43617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43617.